Add Yahoo as a preferred source to see more of our stories on Google. Alzheimer's disease, the most common form of dementia, is responsible for tens of millions of cases around the world. Jens Kalaene ...

Peptinovo Biopharma, an Ann Arbor–based biotechnology company pioneering targeted cancer therapies through its ...

Neuralink is preparing to begin its first human clinical trials of the Blindsight implant in 2026, which aims to restore vision for people with complete blindness.Neuralink Founder Elon Musk ...

For decades, the idea of a drug that could rewind aspects of human aging has belonged more to science fiction than hospital formularies. That boundary is starting to blur as a gene therapy called ...

Add Yahoo as a preferred source to see more of our stories on Google. In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s ...

Memorial Sloan Kettering Cancer Center's mission is to end cancer. To get there, the famed organization must keep improving clinical care and research, including clinical trials. It has as many as ...

Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the first patient was dosed in its first-in-human ...

Researchers hope to launch human clinical trials in their quest for a vaccine to prevent the buildup of pathological tau after demonstrating that this vaccine generated a robust immune response in ...

The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.

Early safety and visual performance signals were reported at 3 months from a first-in-human (FIH) clinical study evaluating ...

A simple seed that you may know from warm curries and Middle Eastern bread is drawing fresh attention from scientists. Black cumin, a spice used for centuries in traditional medicine, is showing early ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...